Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2014-09-30
2015-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In this context, the objective of this project is to characterize the young children's exposure to a particular class of semi volatile organic compounds. It will encompass the relative contribution of different pathways to the external dose, and to try to match the internal and external doses with a physiologically based pharmacokinetic (PBPK) model for molecules for which it is possible.
The present demand concerns a feasibility study on 2 children, for Perfluorinated Alkylated Substances (PFAS), used in numerous consumer products.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Chemometers to Determine the Environmental and Human Exposome by Mixtures of Pollutants
NCT05927077
Immune Tolerance Dysfunction in Pregnancy Due to Ambient Air Pollution Exposure
NCT04549142
Natural History of the Human Biological Response to Environmental Exposure and Injury
NCT04888923
Exposure of Taxi Drivers to Ultrafine Particles and Black Carbon Within Their Vehicles
NCT03839537
Impact of Exposure to Environmental Pollutants on Birth Outcomes in an Israeli Cohort
NCT03084445
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Strategy : Exposure assessment of young children to PFAS with simultaneous measurement of internal (serum) and external doses (diet, indoor environment: contamination data and human exposure factors; quantity ingested and breathed).
Expected outcomes :
Assessment of feasibility to obtain:
* original data on children's body burden
* original contamination data for food, water, air and dust ;
* Matching of these data to identify main sources and pathways of exposure.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exposure study
2-6 months-old children and 12-18 months-old children
Exposure study
Sampling of blood, food, water, air and dust and delivery of dietary questionnaire
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exposure study
Sampling of blood, food, water, air and dust and delivery of dietary questionnaire
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* In outpatient pediatric or pediatric surgery ;
* From their homes ;
* With home located less than 30km from Rennes ;
* Living at their home (not at childcare facility or child-minder);
* With a scheduled blood sampling apart from this study ;
* For child 2 - 6 months :
* With diet exclusively based on milk (maternal exclusively or commercial exclusively)
* In case of breastfeeding, with mother accepting milk sampling ;
* With a free, enlightened and signed written consent from the parents.
Breastfeeding mother :
* \> 18 years ;
* Exclusive breastfeeding ;
* With a free, enlightened and signed written consent.
Exclusion Criteria
* Metabolic illness ;
* Renal or hepatic insufficiency ;
* Malabsorption
* With known HIV+, HBV+, HCV+, CMV+ serology
* Simultaneously participating to other biomedical survey
For breastfeeding mother :
* Under legal protection (judicial protection, guardianship) ;
* mixed breastfeeding ;
* with Known HIV+, HBV+, HCV+, CMV+ serology
6 Months
18 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut de Recherche en Santé, Environnement et le Travail, France
OTHER
Laboratoire d'Etude des Résidus et Contaminants dans les Aliments
UNKNOWN
Institut national de l'environnement industriel et des risques
INDUSTRY
National Agency for Sanitary Safety of the Food of the Environment and Labor
OTHER_GOV
Rennes University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Philippe Glorennec, PhD
Role: STUDY_CHAIR
Inserm UMR 1085 - Institut de Recherche sur la Santé, l'Environnement et le Travail
Florence Rouget, MD
Role: PRINCIPAL_INVESTIGATOR
Rennes University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rennes Hospital University
Rennes, Brittany Region, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2014-A00782-45
Identifier Type: OTHER
Identifier Source: secondary_id
14/25-941
Identifier Type: OTHER
Identifier Source: secondary_id
140682B-82
Identifier Type: OTHER
Identifier Source: secondary_id
35RC13_8917_TEXTO
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.